BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 28385820)

  • 1. Principles of diagnosis and management of neuroendocrine tumours.
    Raphael MJ; Chan DL; Law C; Singh S
    CMAJ; 2017 Mar; 189(10):E398-E404. PubMed ID: 28385820
    [No Abstract]   [Full Text] [Related]  

  • 2. Occipital Headache as Initial Manifestation of a Pancreatic Neuroendocrine Tumor.
    Tsoukalas N; Triantafyllidis A; Tolia M; Galanopoulos M; Kostakis ID; Demiri S; Toumpanakis C; Koumakis G
    J Gastrointest Cancer; 2018 Dec; 49(4):501-503. PubMed ID: 28283989
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Öberg K; Knigge U; Kwekkeboom D; Perren A;
    Ann Oncol; 2012 Oct; 23 Suppl 7():vii124-30. PubMed ID: 22997445
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diagnosis for the gastroenteropancreatic neuroendocrine tumors].
    Komoto I; Imamura M
    Nihon Shokakibyo Gakkai Zasshi; 2014 Dec; 111(12):2263-71. PubMed ID: 25482901
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent updates on grading and classification of neuroendocrine tumors.
    Kim JY; Hong SM; Ro JY
    Ann Diagn Pathol; 2017 Aug; 29():11-16. PubMed ID: 28807335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors.
    Deppen SA; Liu E; Blume JD; Clanton J; Shi C; Jones-Jackson LB; Lakhani V; Baum RP; Berlin J; Smith GT; Graham M; Sandler MP; Delbeke D; Walker RC
    J Nucl Med; 2016 May; 57(5):708-14. PubMed ID: 26769865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gastroenteropancreatic neuroendocrine tumors : targeted diagnostics and therapy].
    Holzer K
    Chirurg; 2014 Aug; 85(8):731-44. PubMed ID: 25103842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Diarrhea in Patients With Carcinoid Syndrome.
    Naraev BG; Halland M; Halperin DM; Purvis AJ; OʼDorisio TM; Halfdanarson TR
    Pancreas; 2019 Sep; 48(8):961-972. PubMed ID: 31425482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Consensus and controversy of endoscopic diagnosis and treatment of gastroenteropancreatic neuroendocrine tumors].
    Chen H; Chen Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):982-986. PubMed ID: 28900987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic imaging of pancreatic neuroendocrine neoplasms (pNEN): tumor detection, staging, prognosis, and response to treatment.
    Baur AD; Pavel M; Prasad V; Denecke T
    Acta Radiol; 2016 Mar; 57(3):260-70. PubMed ID: 25855665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites.
    Sadowski SM; Neychev V; Millo C; Shih J; Nilubol N; Herscovitch P; Pacak K; Marx SJ; Kebebew E
    J Clin Oncol; 2016 Feb; 34(6):588-96. PubMed ID: 26712231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highlights in GEP-NETs From the 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease: Commentary.
    Iyer R; Hatoum H
    Clin Adv Hematol Oncol; 2016 May; 14(5 Suppl 7):17-9. PubMed ID: 27168109
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuroendocrine Tumors.
    Basuroy R; Srirajaskanthan R; Ramage JK
    Gastroenterol Clin North Am; 2016 Sep; 45(3):487-507. PubMed ID: 27546845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologic Classification of Neuroendocrine Neoplasms.
    Klimstra DS
    Hematol Oncol Clin North Am; 2016 Feb; 30(1):1-19. PubMed ID: 26614366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of Interventional Radiology in the management of Gastro-Entero-Pancreatic Neuroendocrine Tumours (GEP-NETs).
    Orgera G; Krokidis M; Cappucci M; Gourtsoyianni S; Tipaldi MA; Hatzidakis A; Rebonato A; Rossi M
    Cardiovasc Intervent Radiol; 2015 Feb; 38(1):13-24. PubMed ID: 25366087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinicopathological characterization of gastro-entero- pancreatic neuroendocrine tumors].
    Borka K
    Magy Onkol; 2018 Jul; 62(2):90-97. PubMed ID: 30027936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of positive
    Zilli A; Fanetti I; Conte D; Massironi S
    Clin Imaging; 2018; 49():156-158. PubMed ID: 29529451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggressive gastro-entero-pancreatic neoplasms.
    Coriat R
    Ann Endocrinol (Paris); 2019 Jun; 80(3):185-186. PubMed ID: 31064660
    [No Abstract]   [Full Text] [Related]  

  • 19. Gastroenteropancreatic Neuroendocrine Tumors.
    Fernandes CJ; Leung G; Eads JR; Katona BW
    Gastroenterol Clin North Am; 2022 Sep; 51(3):625-647. PubMed ID: 36153114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Symptoms and diagnosis of neuroendocrine tumors of the digestive system].
    Gyökeres T
    Orv Hetil; 2011 Mar; 152(10):371-8. PubMed ID: 21354953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.